Secondary progressive sclerosis in Russia, medical and social characteristics of patients and urgent tasks of therapy-Reference-Cited by-同舟云学术

Secondary progressive sclerosis in Russia, medical and social characteristics of patients and urgent tasks of therapy

Published:2021-03-28 Issue:3 Volume: Page:7-13
ISSN:2078-5631
Container-title:Medical alphabet
language:
Short-container-title:Medicinskij alfavit

Author:

Vlasov Ya. V.¹^ORCID,Polyarnaya N. G.²^ORCID,Fomina T. A.²^ORCID,Lasch N. Yu.³,Guseva M. R.³^ORCID,Boyko A. N.⁴^ORCID

Affiliation:

1. Samara State Medical University;All-Russian Public Organization of Disabled People – Patients with Multiple Sclerosis

2. Centre of Humanitarian technologies and research 'Social Dynamics'

3. Pirogov Russian National Research Medical University

4. Pirogov Russian National Research Medical University; Russian Committee of Researchers of Multiple Sclerosis; Institute of Clinical Neurology and Neuroimmunology Department of Federal Brain and Neurotechnologies Center, FMBA

Abstract

Currently, it is possible to treat secondary progressive multiple sclerosis (SPMS). This is the most unfavorable type of multiple sclerosis (MS) and the article provides a medical and social analysis of MS course at this group of patients. There is evidence that these patients are highly socialized members of society, usually family members, so their non-participation in socially useful work significantly affects the whole life of society. Many of them receive pathogenetic treatment drugs that do not work at this stage of MS. That is, the large cost of purchasing medicines not only does not help these patients, but also is an irrational expenditure of public funds.

Publisher

Alfmed LLC

Subject

Materials Chemistry,Economics and Econometrics,Media Technology,Forestry

Reference26 articles.

1. Vlasov YV, Churakov MV, Kurapov MA, Gromova TN, Popova EV, Boyko OV, Spirin NN, Sivertseva SA, Belskaya GN, Malkova NA, Habirov FA, Haybullin TI, Kotov SV, Greshnova IV, Ivashinenkova EI, Bakalova MA, Yampolskaya-Gosteva IA, Boyko AN. [Primary-progressive multiple sclerosis in Russia: a medical-sociological study involving patients and neurologists] Zh Nevrol Psikhiatr Im SS Korsakov. 2018; 8 (2): 40–46. DOI: 10.17116/jnevro201811808240. Russian.

2. Boyko A. Kobelt G, Berg J, Boyko O, Popova E, Capsa D, Eriksson J. New insights into the burden and costs of multiple sclerosis in Europe: Results for Russia. Mult Sler 2017, 23 (2S): 155–165 DOI: 10.1177/ 1352458517708668.

3. Boyko A, Melnikov M. Prevalence and Incidence of Multiple Sclerosis in Russian Federation: 30 Years of Studies. Brain Sci. 2020; 10 (5), E 305. DOI: 10.3390/ brainsci10050305.

4. Compston A, Coles A. Multiple sclerosis. Lancet. 2008; 372 (9648): 1502–1517. DOI: 10.1016/S0140–6736(08)61620–7.

5. Davies F, Edwards A, Brain K, Edwards M, Jones R, Wallbank R, Robertson NP, Wood F. 'You are just left to get on with it': qualitative study of patient and carer experiences of the transition to secondary progressive multiple sclerosis. BMJ Open. 2015; 5 (7): e007674.